Hemostemix OTC Stock Forward View
| HMTXF Stock | USD 0.07 0 1.48% |
Hemostemix OTC Stock outlook is based on your current time horizon. We recommend always using this module together with an analysis of Hemostemix's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 30th of January 2026, The value of RSI of Hemostemix's share price is at 54. This usually indicates that the otc stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Hemostemix, making its price go up or down. Momentum 54
Impartial
Oversold | Overbought |
It is a matter of debate whether otc price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Hemostemix based on different types of headlines from major news networks to social media. Using Hemostemix hype-based prediction, you can estimate the value of Hemostemix from the perspective of Hemostemix response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Hemostemix on the next trading day is expected to be 0.07 with a mean absolute deviation of 0 and the sum of the absolute errors of 0.13. Hemostemix after-hype prediction price | USD 0.07 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Hemostemix |
Hemostemix Additional Predictive Modules
Most predictive techniques to examine Hemostemix price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Hemostemix using various technical indicators. When you analyze Hemostemix charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Hemostemix Naive Prediction Price Forecast For the 31st of January
Given 90 days horizon, the Naive Prediction forecasted value of Hemostemix on the next trading day is expected to be 0.07 with a mean absolute deviation of 0, mean absolute percentage error of 0.00000793, and the sum of the absolute errors of 0.13.Please note that although there have been many attempts to predict Hemostemix OTC Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Hemostemix's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Hemostemix OTC Stock Forecast Pattern
| Backtest Hemostemix | Hemostemix Price Prediction | Buy or Sell Advice |
Hemostemix Forecasted Value
In the context of forecasting Hemostemix's OTC Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Hemostemix's downside and upside margins for the forecasting period are 0.0007 and 5.49, respectively. We have considered Hemostemix's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Hemostemix otc stock data series using in forecasting. Note that when a statistical model is used to represent Hemostemix otc stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 106.366 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0021 |
| MAPE | Mean absolute percentage error | 0.0335 |
| SAE | Sum of the absolute errors | 0.1289 |
Predictive Modules for Hemostemix
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Hemostemix. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Hemostemix's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hemostemix After-Hype Price Density Analysis
As far as predicting the price of Hemostemix at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Hemostemix or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of OTC Stock prices, such as prices of Hemostemix, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Hemostemix Estimiated After-Hype Price Volatility
In the context of predicting Hemostemix's otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Hemostemix's historical news coverage. Hemostemix's after-hype downside and upside margins for the prediction period are 0.00 and 5.54, respectively. We have considered Hemostemix's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Hemostemix is out of control at this time. Analysis and calculation of next after-hype price of Hemostemix is based on 3 months time horizon.
Hemostemix OTC Stock Price Outlook Analysis
Have you ever been surprised when a price of a OTC Stock such as Hemostemix is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Hemostemix backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Hemostemix, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.27 | 5.42 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.07 | 0.07 | 2.04 |
|
Hemostemix Hype Timeline
Hemostemix is currently traded for 0.07. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Hemostemix is anticipated to increase in value after the next headline, with the price projected to jump to 0.07 or above. The average volatility of media hype impact on the company the price is insignificant. The price rise on the next news is projected to be 2.04%, whereas the daily expected return is currently at 0.27%. The volatility of related hype on Hemostemix is about 0.0%, with the expected price after the next announcement by competition of 0.07. Hemostemix has accumulated 1.48 M in total debt. Assuming the 90 days horizon the next anticipated press release will be in a few days. Check out Historical Fundamental Analysis of Hemostemix to cross-verify your projections.Hemostemix Related Hype Analysis
Having access to credible news sources related to Hemostemix's direct competition is more important than ever and may enhance your ability to predict Hemostemix's future price movements. Getting to know how Hemostemix's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Hemostemix may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| NYMXF | Nymox Pharmaceutical | 0.00 | 0 per month | 0.00 | (0.02) | 36.54 | (23.42) | 68.44 | |
| DVHGF | Devonian Health Group | 0.00 | 0 per month | 0.00 | 0.16 | 0.00 | 0.00 | 1,098 | |
| HOOK | Hookipa Pharma | 0.00 | 0 per month | 1.17 | 0.08 | 3.41 | (2.25) | 7.38 | |
| LVCLF | Living Cell Technologies | 0.00 | 0 per month | 0.00 | 0.07 | 0.00 | 0.00 | 61.22 | |
| IMUC | ImmunoCellular Therapeutics | 0.00 | 0 per month | 17.54 | 0.13 | 80.00 | (37.50) | 223.80 | |
| SRBCF | Sirona Biochem Corp | 0.00 | 0 per month | 0.00 | 0.12 | 0.00 | 0.00 | 5,000 | |
| OXBOF | Oxford BioDynamics Plc | 0.00 | 0 per month | 0.00 | 0.02 | 0.00 | (8.00) | 192.86 | |
| INTI | Inhibitor Therapeutics | 0.00 | 0 per month | 6.46 | 0.07 | 11.63 | (12.12) | 107.08 | |
| QPTFF | Quest PharmaTech | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CLCS | Cell Source | 0.00 | 0 per month | 4.53 | 0.23 | 12.50 | (9.09) | 31.62 |
Other Forecasting Options for Hemostemix
For every potential investor in Hemostemix, whether a beginner or expert, Hemostemix's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Hemostemix OTC Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Hemostemix. Basic forecasting techniques help filter out the noise by identifying Hemostemix's price trends.Hemostemix Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Hemostemix otc stock to make a market-neutral strategy. Peer analysis of Hemostemix could also be used in its relative valuation, which is a method of valuing Hemostemix by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Hemostemix Market Strength Events
Market strength indicators help investors to evaluate how Hemostemix otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Hemostemix shares will generate the highest return on investment. By undertsting and applying Hemostemix otc stock market strength indicators, traders can identify Hemostemix entry and exit signals to maximize returns.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 0.0686 | |||
| Day Typical Price | 0.0686 | |||
| Price Action Indicator | 5.0E-4 | |||
| Period Momentum Indicator | 0.001 | |||
| Relative Strength Index | 54.26 |
Hemostemix Risk Indicators
The analysis of Hemostemix's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Hemostemix's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting hemostemix otc stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.84 | |||
| Semi Deviation | 4.06 | |||
| Standard Deviation | 5.47 | |||
| Variance | 29.95 | |||
| Downside Variance | 66.62 | |||
| Semi Variance | 16.52 | |||
| Expected Short fall | (6.53) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Hemostemix
The number of cover stories for Hemostemix depends on current market conditions and Hemostemix's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Hemostemix is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Hemostemix's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Other Information on Investing in Hemostemix OTC Stock
Hemostemix financial ratios help investors to determine whether Hemostemix OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hemostemix with respect to the benefits of owning Hemostemix security.